Results

ObsEva SA

05/09/2022 | Press release | Distributed by Public on 05/08/2022 23:03

ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine Fibroids at the 2022 ACOG Annual Clinical and Scientific Meeting